Effectiveness of second booster compared to first booster and protection conferred by previous SARS CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France

Cynthia Tamandjou, Vincent Auvigne, Justine Schaeffer, Sophie Vaux, Isabelle Parent du Châtelet
doi: https://doi.org/10.1101/2023.01.11.23284137

Data Availability

While all data used in this analysis were pseudonymised, the individual-level nature of the data used risks individuals being identified, or being able to self-identify, if it is released publicly. Requests for access to the underlying source data should be directed to Sante publique France and will be granted in accordance with the GDPR and French Law.

Back to top
Posted February 07, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Effectiveness of second booster compared to first booster and protection conferred by previous SARS CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France
Cynthia Tamandjou, Vincent Auvigne, Justine Schaeffer, Sophie Vaux, Isabelle Parent du Châtelet
medRxiv 2023.01.11.23284137; doi: https://doi.org/10.1101/2023.01.11.23284137
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area